Peter Wenaweser

Showing 1-20 of 28 articles

Interventions for valvular disease

Left ventricular afterload reduction by transcatheter aortic valve implantation in severe aortic stenosis and its prompt effects on comprehensive coronary haemodynamics

Stoller M, Gloekler S, Zbinden R, Tueller D, Eberli F, Windecker S, Wenaweser P, Seiler C

June 20, 2018 | 10.4244/EIJ-D-17-00719

Coronary interventions

Switzerland: coronary and structural heart interventions from 2010 to 2015

Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Rothlisberger C, Corti R, Rickli H, Kaiser C, Roffi M

May 15, 2017 | 10.4244/EIJ-D-16-00828

Interventions for valvular disease

Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis

Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Jüni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M

April 7, 2017 | 10.4244/EIJ-D-16-00677

Coronary interventions

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Mueller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S

December 9, 2016 | 10.4244/EIJY15M12_09

Interventions for valvular disease

Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve

Wenaweser P, Stortecky S, Schütz T, Praz F, Gloekler S, Windecker S, Elsasser A

May 16, 2016 | 10.4244/EIJV12I1A13

Interventions for valvular disease

The 2011-2012 pilot European Society of Cardiology Sentinel Registry of Transcatheter Aortic Valve Implantation: 12-month clinical outcomes

Gilard M, Schlüter M, Snow T, Dall’Ara G, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Price S, Barrero E, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Witkowski A, Danenberg H, Schroeder E, Romeo F, Macaya C, Derumeaux G, Laroche C, Pighi M, Serdoz R, Di Mario C

May 16, 2016 | 10.4244/EIJV12I1A15

Five-year results of a randomised comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularisation

Pilgrim T, Räber L, Limacher A, Wenaweser P, Cook S, Stauffer J-C, Garachemani A, Moschovitis A, Meier B, Jüni P, Windecker S

March 20, 2015 | 10.4244/EIJY15M01_04

Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation

O’Sullivan C, Stortecky S, Heg D, Jüni P, Windecker S, Wenaweser P

February 20, 2015 | 10.4244/EIJV10I10A200

Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry

Wenaweser P, Stortecky S, Heg D, Tueller D, Nietlispach F, Falk V, Pedrazzini G, Jeger R, Reuthebuch O, Carrel T, Räber L, Amann F, Ferrari E, Toggweiler S, Noble S, Roffi M, Gruenenfelder J, Jüni P, Windecker S, Huber C

December 22, 2014 | 10.4244/EIJV10I8A166

Low-flow, low-gradient aortic stenosis: should TAVI be the default therapeutic option?

O’Sullivan C, Wenaweser P

November 20, 2014 | 10.4244/EIJV10I7A134

Extent and distribution of calcification of both the aortic annulus and the left ventricular outflow tract predict aortic regurgitation after transcatheter aortic valve replacement

Buellesfeld L, Stortecky S, Heg D, Gloekler S, Meier B, Wenaweser P, Windecker S

October 20, 2014 | 10.4244/EIJV10I6A126

Assessment of low-flow, low-gradient, severe aortic stenosis: an invasive evaluation is required for decision making

O’Sullivan C, Praz F, Stortecky S, Windecker S, Wenaweser P

September 27, 2014 | 10.4244/EIJV10SUA9

Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat

Stefanini G, Stortecky S, Wenaweser P, Windecker S

September 27, 2014 | 10.4244/EIJV10SUA10

Accuracy and reproducibility of aortic annulus sizing using a dedicated three-dimensional computed tomography reconstruction tool in patients evaluated for transcatheter aortic valve replacement

Stortecky S, Heg D, Gloekler S, Wenaweser P, Windecker S, Buellesfeld L

July 21, 2014 | 10.4244/EIJV10I3A59

Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents

O’Sullivan C, Stefanini G, Räber L, Heg D, Taniwaki M, Kalesan B, Pilgrim T, Zanchin T, Moschovitis A, Büllesfeld L, Khattab A, Meier B, Wenaweser P, Jüni P, Windecker S

January 20, 2014 | 10.4244/EIJV9I9A182

Transcatheter aortic valve implantation: the transfemoral access route is the default access

Stortecky S, O’Sullivan C, Buellesfeld L, Windecker S, Wenaweser P

September 15, 2013 | 10.4244/EIJV9SSA4

Severe aortic stenosis and coronary artery disease

Stefanini G, Stortecky S, Meier B, Windecker S, Wenaweser P

September 15, 2013 | 10.4244/EIJV9SSA12

The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

Di Mario C, Eltchaninoff H, Moat N, Goicolea J, Ussia G, Kala P, Wenaweser P, Zembala M, Nickenig G, Barrero E, Snow T, Iung B, Zamorano P, Schuler G, Corti R, Alfieri O, Prendergast B, Ludman P, Windecker S, Sabate M, Gilard M, Witkowski A, Danenberg H, Schröder E, Romeo F, Macaya C, Derumeaux G, Maggioni A, Tavazzi L

April 19, 2013 | 10.4244/EIJV8I12A209

Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents

Pilgrim T, Kalesan B, Zanchin T, Pulver C, Jung S, Mattle H, Carrel T, Moschovitis A, Stortecky S, Wenaweser P, Stefanini G, Räber L, Meier B, Jüni P, Windecker S

January 18, 2013 | 10.4244/EIJV8I9A163

Transcatheter aortic valve implantation and cerebrovascular accidents

Stortecky S, Wenaweser P, Windecker S

September 30, 2012 | 10.4244/EIJV8SQA11

1
2

Latest news

Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...

An Occlutech PLD Occluder 8×4 mm is positioned through a 7 Fr catheter

November 20, 2020

Impact of Pulmonary Ridge Coverage after Left Atrial Appendage Occlusion

November 18, 2020

Lifelong learning never stops. PCR London Valves goes virtual!

November 20, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Patient preferences and Heart Team decision

November 20, 2020

This Week's JAA's: Win Ratio for Renal Denervation, Optimal strategy for NSTEMI in the very elderly, D-PUSH OCT Procedure...

November 24, 2020

Valvular disease